Evaluation of the chemosensitivity of primary cultured malignant melanoma cells using the collagen gel droplet-embedded culture drug sensitivity test
- PMID: 23136594
- PMCID: PMC3490383
- DOI: 10.3892/etm_00000011
Evaluation of the chemosensitivity of primary cultured malignant melanoma cells using the collagen gel droplet-embedded culture drug sensitivity test
Abstract
Malignant melanoma usually shows resistance to a standard chemotherapy regimen. A useful in vitro method to evaluate individual chemosensitivity is required to select effective anti-cancer drugs. This study aimed to establish in vitro tumor response testing for malignant melanoma. We determined the chemosensitivity of primary cultured melanoma cells using the collagen gel droplet-embedded culture drug sensitivity test (CD-DST). Nineteen tests were carried out for 15 cases of malignant melanoma. Primary cultured melanoma cells in collagen gel droplets were exposed to anti-cancer drugs, including cisplatin, adriamycin, dacarbazine, nimustine and vincristine. After a 7-day incubation in a serum-free medium, living melanoma cells in a collagen droplet were detected by image analysis after staining with Neutral red reagent. In vitro drug exposure conditions were determined to reproduce the value of the plasma area under the time-drug concentration curve in vivo. The rate of evaluation of the primary culture of melanoma cells was 78.9% (15/19 tests). The chemosensitivity of cisplatin, adriamycin, dacarbazine, nimustine and vincristine was 15, 62, 0, 0 and 62%, respectively. Dacarbazine was not suitable for CD-DST due to its prodrug characteristics. The CD-DST method was able to evaluate the chemosensitivity of malignant melanoma to anti-cancer drugs in vitro. This method can also be applied to estimate the efficacy of newly developed anti-cancer drugs in vitro.
Figures


Similar articles
-
In vitro-chemosensitivity test using the collagen gel droplet embedded culture drug test (CD-DST) for malignant pleural mesothelioma: possibility of clinical application.Ann Thorac Cardiovasc Surg. 2008 Dec;14(6):355-62. Ann Thorac Cardiovasc Surg. 2008. PMID: 19131921
-
Collagen gel droplet culture method to examine in vitro chemosensitivity.Methods Mol Med. 2005;110:59-67. doi: 10.1385/1-59259-869-2:059. Methods Mol Med. 2005. PMID: 15901927
-
An in vitro chemosensitivity test for colorectal cancer using collagen-gel droplet embedded cultures.Kurume Med J. 1999;46(3-4):163-6. doi: 10.2739/kurumemedj.46.163. Kurume Med J. 1999. PMID: 10659592
-
Development of a new in vitro chemosensitivity test using collagen gel droplet embedded culture and image analysis for clinical usefulness.Recent Results Cancer Res. 2003;161:48-61. doi: 10.1007/978-3-642-19022-3_5. Recent Results Cancer Res. 2003. PMID: 12528798 Review.
-
[Progress of individualized chemotherapy guided by chemosensitivity test].Yao Xue Xue Bao. 2009 Nov;44(11):1187-92. Yao Xue Xue Bao. 2009. PMID: 21355317 Review. Chinese.
References
-
- Buzaid AC, Bedikian A, Houghton AN. Cutaneous Melanoma. 3rd edition. Quality Medical Publishing; St. Louis: 1998. pp. 405–418.
-
- Balch CM, Reintgen DS, Kirkwood JN, et al. Cancer: Principles and Practice of Oncology. 5th edition. Lippincot-Raven Publishers; Philadelphia: 1997. pp. 1947–1994.
-
- Kobayashi H, Tanisaka K, Doi O, et al. An in vitro chemosensitivity test for solid human tumors using collagen gel droplet embedded cultures. Int J Oncol. 1997;11:449–455. - PubMed
-
- Mitsuhashi Y, Sugiyama Y, Ozawa S, et al. Prediction of ANCU plasma concentration-time profiles in humans by animal scale up. Cancer Chemother Pharmacol. 1990;27:20–26. - PubMed
-
- Breithaupt H, Dammann A, Aigner K. Pharmacokinetics of dacarbazine (DITC) and its metabolite 5-aminoimidazole-4-carboxamide (AIC) following different dose schedules. Cancer Chemother Pharmacol. 1982;9:103–109. - PubMed
LinkOut - more resources
Full Text Sources